Table 5 BZRA molecules and categories of duration of action
Admission | Discharge | p value | |
|---|---|---|---|
Regular use | |||
BZRA frequent molecules | |||
Alprazolam | 101 [14.7%] | 88 [15.6%] | <.001 |
Bromazepam | 63 [9.1%] | 46 [8.2%] | |
Lorazepam | 208 [30.2%] | 251 [44.6%] | |
Lormetazepam | 73 [10.6%] | 65 [11.5%] | |
Zolpidem | 71 [10.3%] | 55 [9.8%] | |
BZRA categories | |||
Short-acting | 91 [13.2%] | 75 [12.2%] | .025 |
Medium-acting | 488 [70.8%] | 470 [76.7%] | |
Long-acting | 110 [16.0%] | 68 [11.1%] | |
Rescue use | |||
BZRA frequent molecules | |||
Alprazolam | 27 [31.4%] | 18 [23.7%] | .040 |
Bromazepam | 4 [4.7%] | 4 [5.3%] | |
Lorazepam | 15 [17.4%] | 43 [56.6%] | |
prazepam | 24 [27.9%] | 3 [3.9%] | |
BZRA categories | |||
Short-acting | 5 [5.9%] | 2 [2.7%] | <.001 |
Medium-acting | 51 [60.0%] | 67 [89.3%] | |
Long-acting | 29 [34.1%] | 6 [8.0%] | |